ArticleGenetics2026
Incorporating experimental mortality improves statistical inference of crossover patterning along meiotic chromosomes.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Classic recombination experiments designed to test genetic and environmental treatments do not directly measure chromosomal exchange, instead rates and distribution of crossing-over in F1 meiocytes are inferred from genetic markers in F2 adults. In Drosophila melanogaster females this procedure introduces substantial "missing data problems" because 75% of meiotic chromatids segregate to polar body nuclei and another 11% are transmitted to inviable F2 zygotes which cannot be scored for recombination. To address these sources of uncertainty and bias, we extend the Cx(Co)m data-generating process by assuming: (i) programmed double-strand breaks occur as a Poisson point process, (ii) crossover maturation is a stationary renewal process, (iii) chromosome segregation is random one-half thinning of this process, (iv) fertilization by X- versus Y-bearing sperm is mendelian, and (v) egg-to-adult survival is binomially distributed with a ate parameter determined by F2 marker alleles. To quantify experimental mortality, we performed egg counts for 6-point X chromosome testcrosses and marker-free X chromosome controls on identical genetic backgrounds under standard laboratory conditions. The 19,927 fly dataset revealed 44% F2 experimental mortality, and likelihood ratio tests support a model where 36 of those 44% are due to sex-specific, marker-associated viability defects. Variability in X chromosome genetic map lengths with experimental mortality can be simulated, and we provide case-control 80% power curves to guide experimental design. We propose that differential mortality should be the de facto null hypothesis when comparing F2 recombinant fractions, and we provide probabilistic models of the data-generating process to improve characterization of F1 meiotic crossover patterning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.